Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SANOFICONRNSE
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 21% |
| - | - | - | 33% |
| - | - | - | -21% |
| 81% | 81% | 81% | 73% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
SANOFICONR
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 3,980 | ₹9226 Cr | 34.68 | 29.91 | 121.23 | ₹240 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|
| — | — | — |
| ₹23 Cr | ₹23 Cr | ₹2 Cr |
| ₹0 | ₹1 Cr | ₹23 Cr |
| ₹361 Cr | ₹249 Cr | ₹183 Cr |
| ₹361 Cr | ₹249 Cr | ₹183 Cr |
| ₹384 Cr | ₹273 Cr | ₹208 Cr |
| -₹9 Cr | -₹6 Cr | -₹2 Cr |
| ₹17 Cr | ₹17 Cr | ₹0 |
| ₹221 Cr | ₹11 Cr | ₹8 Cr |
| ₹230 Cr | ₹22 Cr | ₹6 Cr |
| — | — | — |
| ₹80 Cr | ₹70 Cr | ₹60 Cr |
| ₹13 Cr | ₹18 Cr | ₹0 |
| ₹36 Cr | ₹164 Cr | ₹70 Cr |
| ₹128 Cr | ₹252 Cr | ₹130 Cr |
| ₹742 Cr | ₹547 Cr | ₹344 Cr |
| ₹2 Cr | ₹60 L | ₹0 |
| — | — | — |
| ₹58 Cr | ₹40 Cr | ₹11 Cr |
| ₹23 Cr | ₹11 Cr | ₹6 Cr |
| ₹36 Cr | ₹29 Cr | ₹5 Cr |
| ₹0 | ₹70 L | ₹0 |
| ₹211 Cr | ₹2 Cr | ₹0 |
| ₹70 L | ₹1 Cr | ₹80 L |
| ₹248 Cr | ₹33 Cr | ₹8 Cr |
| — | — | — |
| ₹62 Cr | ₹41 Cr | ₹97 Cr |
| ₹30 Cr | ₹14 Cr | ₹32 Cr |
| ₹375 Cr | ₹327 Cr | ₹2 Cr |
| ₹3 Cr | ₹6 Cr | ₹205 Cr |
| ₹25 Cr | ₹126 Cr | ₹60 L |
| ₹494 Cr | ₹513 Cr | ₹335 Cr |
| ₹366 Cr | ₹261 Cr | ₹205 Cr |
| ₹742 Cr | ₹547 Cr | ₹344 Cr |
| ₹167 | ₹118 | ₹923 |
| ₹167 | ₹118 | ₹923 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|
| ₹320 Cr | ₹247 Cr | ₹219 Cr |
| -₹4 Cr | ₹50 L | -₹2 Cr |
| -₹54 Cr | ₹316 Cr | -₹213 Cr |
| ₹262 Cr | ₹563 Cr | ₹4 Cr |
| ₹175 Cr | ₹439 Cr | -₹40 L |
| ₹8 Cr | ₹2 Cr | ₹0 |
| -₹135 Cr | -₹116 Cr | ₹2 Cr |
| ₹48 Cr | ₹325 Cr | ₹2 Cr |
| ₹327 Cr | ₹2 Cr | ₹0 |
| ₹375 Cr | ₹327 Cr | ₹2 Cr |
Fundamental Ratios
Consolidated
Standalone
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 6 out of 9 oscillators
RSI
31.36Sell
STOCH %K
14.66Buy
MACD Level(12,26)
-94.02Sell
Ultimate Oscillator
38.38Sell
Aroon Oscillator
-70.00Sell
BOP
-0.24Sell
CCI
-86.40Neutral
Williams %R
-85.34Buy
Momentum
-234.10Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
4015.79Sell
SMA 9
4006.59Sell
EMA 21
4093.87Sell
SMA 21
4084.27Sell
EMA 50
4256.78Sell
SMA 50
4323.76Sell
EMA 200
4496.82Sell
SMA 200
4447.44Sell
WMA 20
4041.52Sell
Pivot
Pivot
Classic
Resistance 5
4319.33
Resistance 4
4239.13
Resistance 3
4158.93
Resistance 2
4078.73
Resistance 1
4042.07
Pivot
3998.53
Support 1
3961.87
Support 2
3918.33
Support 3
3838.13
Support 4
3757.93
Support 5
3677.73
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 71.27% | 71.27% | 71.27% | 71.27% | 71.27% | 60.40% |
| 2.60% | 2.75% | 2.83% | 2.93% | 3.24% | 4.52% |
| 4.84% | 3.94% | 3.87% | 3.87% | 4.04% | 9.81% |
| 13.01% | 13.63% | 13.46% | 13.34% | 12.85% | 15.09% |
| 8.28% | 8.41% | 8.57% | 8.59% | 8.60% | 10.18% |
Bulk & block deals
Name
Opella Healthcare Participations B V
Hoechst Gmbh
Opella Healthcare Participations B V
Hoechst Gmbh
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 10 Oct 2024 | Purchase | 6,927.40 Cr | ₹4,982.05 | 1.39 Cr | Bulk | 60.374988 | BSE |
| 10 Oct 2024 | Sell | 6,927.40 Cr | ₹4,982.05 | 1.39 Cr | Bulk | 60.374988 | BSE |
| 10 Oct 2024 | Purchase | 6,927.40 Cr | ₹4,982.05 | 1.39 Cr | Block | 60.374988 | BSE |
| 10 Oct 2024 | Sell | 6,927.40 Cr | ₹4,982.05 | 1.39 Cr | Block | 60.374988 | BSE |
Insider trading & SAST
Client name
Nippon India Mutual Fund
Opal Bidco Sas
Opal Bidco Sas
Opella Healthcare Participations Bv
Opella Healthcare Participations Bv
Sanofi
Sanofi
Opella Healthcare Participations B.v.
Opella Healthcare Participations Bv
Hoechst Gmbh
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09 Jun 2026 | Other | Acquisition | 0.13 | 5.04 | 0 | — | 30 K | 14 Jun 2024 - 29 Apr 2026 | Market | 11,62,073 | SAST | 29(1) | — |
| 03 Jul 2025 | Promoter | Acquisition | 10.87 | 10.87 | 0 | — | 25.05 L | 11 Jun 2025 | Open Offer | 25,04,630 | SAST | 29(1) | — |
| 13 Jun 2025 | Promoter Group | Acquisition | 10.875227 | 10.87 | 1,247.82 Cr | ₹4,982.05 | 25.05 L | 11 Jun 2025 | Off Market | 25,04,630 | Insider Trading | — | Equity Shares |
| 06 Nov 2024 | Other | Acquisition | 0.02 | — | 0 | — | 4.87 K | 10 Oct 2024 | - | — | SAST | 10(6) | — |
| 06 Nov 2024 | Promoter | Acquisition | 0.02 | 60.4 | 0 | — | 4.87 K | 25 Oct 2024 | Inter-se Transfer | 1,39,09,587 | SAST | 29(2) | — |
| 06 Nov 2024 | Promoter | Disposal | 0.02 | — | 0 | — | 4.87 K | 25 Oct 2024 | Inter-se Transfer | — | SAST | 29(2) | — |
| 28 Oct 2024 | Promoter | Disposal | 0.021124 | 0 | 2.33 Cr | ₹4,781.85 | 4.87 K | 25 Oct 2024 | Inter-se Transfer | 0 | Insider Trading | — | Equity Shares |
| 28 Oct 2024 | Promoter | Acquisition | 0.021124 | 60.4 | 2.33 Cr | ₹4,781.85 | 4.87 K | 25 Oct 2024 | Inter-se Transfer | 1,39,09,587 | Insider Trading | — | Equity Shares |
| 24 Oct 2024 | Other | Acquisition | 60.37 | — | 0 | — | 1.39 Cr | 10 Oct 2024 | - | — | SAST | 10(6) | — |
| 24 Oct 2024 | Promoter | Disposal | 60.37 | — | 0 | — | 1.39 Cr | 10 Oct 2024 | Inter-se Transfer | — | SAST | 29(2) | — |
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Sanofi Consumer Healthcare India was incorporated and domiciled in India on May 10, 2023, having its registered office at Vikhroli East, Mumbai. It is primarily engaged in the business of
Corporate Actions
Date
Type
Details
Company details
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Sanofi Consumer Healthcare India Share Price
3971.30-34.10 (-0.85%)
-21.33% past 1 Year
News
Sanofi Consumer Healthcare India posts strong Q1 EBITDA growth and margin expansion
Equity
SANOFICONR
Sanofi Consumer Healthcare India reports Q1 revenue growth to Rs 236 crore
Equity
SANOFICONR
Sanofi Consumer Healthcare India Q1 net profit rises on year-on-year basis
Equity
SANOFICONR
Sanofi Consumer Healthcare India informs about disclosures
Equity
SANOFICONR
Sanofi Cons. Health - Quaterly Results
Equity
SANOFICONR
Sanofi Consumer Healthcare India informs about outcome of board meeting
Equity
SANOFICONR
Sanofi Consumer Healthcare India Q4 EBITDA Rises 38.8% YoY to Rs 88.80 Crores.
Equity
SANOFICONR
Sanofi Consumer Healthcare India Q4FY25 Net Profit Rises 35.6% YoY to Rs 67.80 Crores.
Equity
SANOFICONR
Sanofi Cons. Health reports Profit after tax of 67.80 Crores, in the March 2026 quarter
Equity
SANOFICONR
Sanofi Consumer Healthcare India informs about investor meet
Equity
SANOFICONR
Sanofi Consumer Healthcare India’s net profit grows 50% in Q4
Equity
SANOFICONR
Sanofi Cons. Health reports Profit after tax of 66.50 Crores, in the December 2025 quarter
Equity
SANOFICONR
Sanofi Consumer Healthcare India Advises Final Dividend of Rs 75 Per Equity Share.
Equity
SANOFICONR
Sanofi Consumer Healthcare India Q3 EBITDA Rises 44.6% YoY to Rs 89.80 Crores.
Equity
SANOFICONR
Sanofi Consumer Healthcare India Q3 Net Profit Rises 50% YoY to Rs 66.50 Crores, Revenue Up 47% to Rs 250 Crores.
Equity
SANOFICONR
Sanofi Consumer Healthcare India submits board meeting intimation
Equity
SANOFICONR
Sanofi Cons. Health reports Profit after tax of 62.90 Crores, in the September 2025 quarter
Equity
SANOFICONR
Sanofi Consumer Healthcare India zooms on reporting over two-fold jump in Q2 net profit
Equity
SANOFICONR
Sanofi Consumer Healthcare India reports over two-fold jump in Q2 net profit
Equity
SANOFICONR
Sanofi Cons. Health - Quaterly Results
Equity
SANOFICONR